Trending Articles

article thumbnail

AI tool could help doctors ID breast cancers vulnerable to Enhertu

Bio Pharma Dive

Tumors with low- and ultra-low levels of a protein called HER2 are treatable with Enhertu, but harder to identify. New research shows AI can improve diagnosis.

Doctors 159
article thumbnail

Big Moves for Bigger Impact: Elevating Agency Leadership to Enhance Client Success

Intouch Solutions

At EVERSANA INTOUCH, we are excited to announce leadership appointments that will directly benefit our pharmaceutical clients. These changes are designed to enhance our ability to deliver value-led advertising, market access, media, medical communications, and transformation solutions, ensuring that our clients receive unparalleled impact and strategic excellence.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pathos AI raises $365m for oncology drug development

Pharmaceutical Technology

Pathos AI has raised $365m in a Series D funding round to widen its AI-enabled platform to advance the development of oncology drugs.

article thumbnail

No cardiac safety concerns reported with a pharmaceutically manufactured cannabidiol formulation

Medical Xpress

A pharmaceutically produced cannabidiol formulation had a good overall safety profile, including cardiac safety, according to research presented at Heart Failure 2025.

article thumbnail

How to Turn “Check-the-Box” Compliance Trainings Into Real Learning

Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group

Let’s face it—most ethics and compliance trainings aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, relevant, and maybe even enjoyable! Join expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training programs. You’ll discover creative strategies to turn traditionally dry topics into meaningful learning experiences that resonate and drive real change.

article thumbnail

World first as infant gets personalised CRISPR therapy

pharmaphorum

In a medical breakthrough, a child diagnosed with a rare genetic disorder has received a bespoke CRISPR gene editing therapy to correct the mutation

article thumbnail

The Vital Role of Heritage for Clinical Research Participants and Professionals

ACRP blog

In recognition of Asian American, Native Hawaiian, and Pacific Islander ( AANHPI ) Heritage Month this May, ACRP asked Sharleen Traynor, PhD, MPH, ACRP-CP, Director of the Clinical Trials Research Associate Program at Durham Technical Community College in North Carolina, to share her thoughts on the importance that AANHPI heritage has had in her life and more broadly in the clinical research enterprise, both for participants and professionals.

More Trending

article thumbnail

Eli Lilly strikes $1.3bn gene therapy deal with Rznomics

Pharmaceutical Technology

The deal gives Lilly access to the companys RNA-editing platform to develop therapies for sensorineural hearing loss.

article thumbnail

US approves first blood test for Alzheimer's

Medical Xpress

The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment earlier with newly approved drugs that slow the progression of the devastating neurological disease.

Drugs 100
article thumbnail

Datavant, Aetion merger creates real-world data force

pharmaphorum

Datavant and Aetion merger promises "faster, more actionable" real-world data insights across pharma's clinical and commercial lifecycle

83
article thumbnail

Novo CEO to depart as obesity drugmaker’s challenges rise

Bio Pharma Dive

Lars Fruergaard Jørgensen will step down after eight years helming the Danish drugmaker, shares of which have lost more than half their value over the past 12 months.

159
159
article thumbnail

Clinical Research White Paper – Enhancing Transparency & Efficiency Throughout the Trial Lifecycle

Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness

article thumbnail

Newborn screening strategy needs modernising as HHS disbands advisory committee 

Pharmaceutical Technology

The Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) was terminated in April.

130
130
article thumbnail

Better than stitches: Researchers develop biocompatible patch for soft organ injuries

Medical Xpress

University of California, Los Angeles and University of California, San Diego researchers developed an injectable sealant for rapid hemostasis and tissue adhesion in soft, elastic organs.

article thumbnail

Kettering Health Cyberattack Triggers System-Wide Outage Across 14 Hospitals

XTalks

On May 20, 2025, Kettering Health experienced a system-wide technology outage caused by a ransomware attack , disrupting services across its 14 medical centers in Ohio. The incident led to the cancellation of elective inpatient and outpatient procedures, disabled the systems call center and interrupted access to patient portals such as MyChart. Emergency rooms and outpatient clinics remain open.

article thumbnail

Healthcare Social Media Marketing in the Age of AI

Pharma Marketing Network

In today’s digital landscape, the integration of artificial intelligence (AI) into healthcare social media marketing is revolutionizing how organizations engage with patients and professionals. As AI technologies become more sophisticated, they offer unprecedented opportunities to personalize content, predict trends, and optimize campaigns. This evolution is not just a trend but a fundamental shift in how healthcare entities communicate and build trust with their audiences.

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

BioMarin to buy rare disease drugmaker Inozyme for $270M

Bio Pharma Dive

The deal “fits like a glove” for BioMarin’s business, according to an analyst who also thinks there could be a “valuable” market opportunity for Inozyme’s main drug.

Marketing 170
article thumbnail

Pharma’s AI prospects get nudged into the future with EU’s AI act 

Pharmaceutical Technology

Experts predict growing pains as the life sciences sector moves to adapt to the EU AI Act.

article thumbnail

Easily distracted? How to improve your attention span

Medical Xpress

Feel like you can't focus? Like you'll never finish a book again? Like the only way to keep your mind and hands busy is to scroll on social media for hours?

81
article thumbnail

Type 1 Diabetes Clinical Research: The Science of Regenerative Therapeutic Cell Technology

XTalks

Diabetes affects hundreds of millions worldwide currently, about 537 million people live with the condition, with projections reaching nearly 643 million by 2030. These figures underline the urgency for novel and more effective treatment strategies, particularly for type 1 diabetes (T1D). Although T1D accounts for only about 5% to 10% of all diabetes cases , its onset at a young age and the need for lifelong management present unique challenges.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FDA clears first blood test for Alzheimer's disease

pharmaphorum

The FDA has approved the first blood test for Alzheimer's disease based on a blood test from Fujirebio in a step forward for early diagnosis

52
article thumbnail

Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff

Bio Pharma Dive

A federal jury found Amgen liable for violating antitrust and tort laws. Elsewhere, Allogene and Kyverna trimmed staff and the FDA scheduled an advisory meeting.

146
146
article thumbnail

Henrik Watz, MD, PhD, Presents Promising Asthma Trial Results at ATS 2025

Velocity Clinical Research

Henrik Watz, MD, PhD, presented compelling real-world data at the American Thoracic Society Annual Meeting on the long-term impact of dupilumab therapy in patients with severe asthma. Participants in the ProVENT study experienced sustained improvements in lung function, asthma control, and quality of life. Notably, more than half achieved asthma remission within two years of treatment.

Trials 52
article thumbnail

Genetic ancestry and parental smoking linked to new genetic changes in children

Medical Xpress

Ancestry and lifestyle choices of parents may affect the rate and type of new genetic changes that arise in their children, new research has found.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

World Schizophrenia Awareness Day 2025: Advances in Precision-Driven Clinical Research

XTalks

Observed each year on May 24, World Schizophrenia Awareness Day shines a light on one of the most misunderstood mental health conditions. Schizophrenia is a chronic psychiatric disorder that alters how individuals perceive reality, think and relate to others. Symptoms are typically categorized as positive (hallucinations, delusions), negative (emotional withdrawal, social disconnection) or cognitive (memory or attention deficits).

article thumbnail

FDA finally okays Novavax's COVID-19 jab, with restrictions

pharmaphorum

FDA finally okays Novavax's COVID-19 jab, with restrictions Phil.

52
article thumbnail

Novo pressures GLP-1 compounders as FDA ban takes hold

Bio Pharma Dive

The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off versions that have dented its sales forecasts.

Sales 130
article thumbnail

Cancer vaccines and the push toward patient-centric trials

Drug Discovery World podcast

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation withPhil L’Huillier, CEO of Scancell. Following the companys recent partnership with the NHS Cancer Vaccine Launch Pad, enabling fast-tracked access for melanoma patients, we discuss how Scancell is addressing the scientific, clinical, and logistical challe

article thumbnail

Can Your Organization Spot a Conflict Before It’s a Crisis?

Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk

In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?

article thumbnail

Dopamine and noradrenaline linked to hippocampal activation during light exercise

Medical Xpress

Researchers at the University of Tsukuba investigated whether monoamine neurotransmitters, such as dopamine, are involved in hippocampal activation even during light exercise. Dopamine secreted from the ventral tegmental area of the brainstem and noradrenaline secreted from the locus coeruleus were hypothesized to be involved in a brain neural circuit that regulates hippocampal activation during light exercise.

article thumbnail

Radiopharmaceuticals and the Future of Nuclear Medicine with RadioMedix CEO Dr. Ebrahim Delpassand — Episode 209

XTalks

In this episode, Ayesha speaks with Ebrahim S. Delpassand, MD, Founder and CEO of RadioMedix , a company developing innovative radiopharmaceuticals for cancer diagnosis, monitoring and treatment. With a focus on both PET imaging and therapeutic radiopharmaceuticals labeled with alpha and beta emitters, RadioMedix is helping to shape the future of precision oncology.

article thumbnail

Limiting the Use of Spread Pricing

Pharmaceutical Commerce

In an exclusive sit-down with Pharma Commerce, Anne Cassity, senior vice president of government affairs for the National Community Pharmacists Association (NCPA), discusses pending legislation that could affect the impact of PBM pricing.

52
article thumbnail

FDA advisers pan Pfizer’s PARP drug; Sarepta to resume Duchenne study

Bio Pharma Dive

An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K. regulators cleared Sarepta to restart an Elevidys study and Altos Labs bought a startup.

article thumbnail

White Paper - A Roadmap to AI Data Readiness in R&D Labs

Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.